van Brouwershaven T, Poppe A, Pijnenborg G, Aleman A, Boonstra N, Gangadin S
Brain Sci. 2025; 15(1).
PMID: 39851383
PMC: 11763429.
DOI: 10.3390/brainsci15010015.
Farina E, Assaf M, Corbera S, Choi J, Yantz C, Chen C
J Psychiatr Res. 2025; 182:74-82.
PMID: 39799666
PMC: 11830537.
DOI: 10.1016/j.jpsychires.2025.01.006.
Luther L, Raugh I, Grant P, Beck A, Strauss G
Schizophr Bull. 2024; 50(6):1427-1435.
PMID: 39066666
PMC: 11548930.
DOI: 10.1093/schbul/sbae128.
Yamanushi A, Shimada T, Koizumi A, Kobayashi M
Biomedicines. 2024; 12(7).
PMID: 39062072
PMC: 11274551.
DOI: 10.3390/biomedicines12071498.
Boskovic D, Smith-Palmer J, Pohlmann J, Pollock R, Hwang S, Bruhn D
Patient Relat Outcome Meas. 2024; 15:199-217.
PMID: 38911609
PMC: 11192194.
DOI: 10.2147/PROM.S454845.
Combining transcranial magnetic stimulation with training to improve social cognition impairment in schizophrenia: a pilot randomized controlled trial.
Vergallito A, Gramano B, La Monica K, Giuliani L, Palumbo D, Gesi C
Front Psychol. 2024; 15:1308971.
PMID: 38445059
PMC: 10912559.
DOI: 10.3389/fpsyg.2024.1308971.
Systematic Review and Meta-analysis of Exercise Interventions for Psychotic Disorders: The Impact of Exercise Intensity, Mindfulness Components, and Other Moderators on Symptoms, Functioning, and Cardiometabolic Health.
Rissmayer M, Kambeitz J, Javelle F, Lichtenstein T
Schizophr Bull. 2024; 50(3):615-630.
PMID: 38394386
PMC: 11651296.
DOI: 10.1093/schbul/sbae015.
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia.
Turkoz I, Wong J, Chee B, Siddiqui U, Knight R, Richarz U
Ther Adv Psychopharmacol. 2023; 13:20451253231200258.
PMID: 37786804
PMC: 10541743.
DOI: 10.1177/20451253231200258.
Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
Agarwal S, Dissanayake J, Agid O, Bowie C, Brierley N, Chintoh A
PLoS One. 2023; 18(9):e0288354.
PMID: 37733693
PMC: 10513234.
DOI: 10.1371/journal.pone.0288354.
Ecological Momentary Assessment Of State Fluctuations In Mindfulness And Symptoms In Psychotic Disorders.
Raugh I, Spilka M, Luther L, Suveg C, Strauss G
J Contextual Behav Sci. 2023; 29:219-229.
PMID: 37720056
PMC: 10501155.
DOI: 10.1016/j.jcbs.2023.08.002.
A meta-analysis of the association between mindfulness and motivation.
Li L, Meng X, Hu W, Geng J, Cheng T, Luo J
Front Public Health. 2023; 11:1159902.
PMID: 37614448
PMC: 10442577.
DOI: 10.3389/fpubh.2023.1159902.
Qualitatively Different Delay-Dependent Working Memory Distortions in People With Schizophrenia and Healthy Control Participants.
Bansal S, Bae G, Robinson B, Dutterer J, Hahn B, Luck S
Biol Psychiatry Cogn Neurosci Neuroimaging. 2023; 8(12):1218-1227.
PMID: 37459911
PMC: 10792108.
DOI: 10.1016/j.bpsc.2023.07.004.
The Correlation of Positive and Negative Symptoms (PANSS Scores) in Patients with Schizophrenia According to Gender.
Sulejmanpasic G, Memic-Serdarevic A, Sabanagic-Hajric S, Bajramagic N
Med Arch. 2023; 77(2):123-126.
PMID: 37260804
PMC: 10227848.
DOI: 10.5455/medarh.2023.77.123-126.
Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
Raugh I, Luther L, Bartolomeo L, Gupta T, Ristanovic I, Pelletier-Baldelli A
Schizophr Res. 2023; 256:79-87.
PMID: 37172500
PMC: 10262695.
DOI: 10.1016/j.schres.2023.04.015.
Qualitatively different delay-dependent working memory distortions in people with schizophrenia and healthy control subjects.
Bansal S, Bae G, Robinson B, Dutterer J, Hahn B, Luck S
bioRxiv. 2023; .
PMID: 37066149
PMC: 10104073.
DOI: 10.1101/2023.04.04.535597.
Do the negative symptoms of schizophrenia reflect reduced responsiveness to reward? Examination using a reward prediction error (RPE) task.
Fuentes-Claramonte P, Garcia-Leon M, Salgado-Pineda P, Ramiro N, Soler-Vidal J, Torres M
Psychol Med. 2023; 53(15):7106-7115.
PMID: 36987680
PMC: 10719670.
DOI: 10.1017/S0033291723000521.
Racial disparities and predictors of functioning in schizophrenia.
Merritt C, Halverson T, Elliott T, Jarskog L, Pedersen C, Penn D
Am J Orthopsychiatry. 2023; 93(3):177-187.
PMID: 36931838
PMC: 10175100.
DOI: 10.1037/ort0000661.
Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptoms.
Zhang T, Gan R, Zeng J, Ye J, Hu Y, Xu L
Eur Arch Psychiatry Clin Neurosci. 2023; 273(8):1725-1736.
PMID: 36688979
DOI: 10.1007/s00406-023-01556-3.
Mediators of quality of life change in people with severe psychotic disorders treated in integrated care: ACCESS II study.
Schroter R, Lambert M, Rohenkohl A, Kraft V, Ruhl F, Luedecke D
Eur Psychiatry. 2022; 66(1):e1.
PMID: 36329654
PMC: 9879911.
DOI: 10.1192/j.eurpsy.2022.2332.
Negative symptoms correlate with altered brain structural asymmetry in amygdala and superior temporal region in schizophrenia patients.
Huang Z, Ruan D, Huang B, Zhou T, Shi C, Yu X
Front Psychiatry. 2022; 13:1000560.
PMID: 36226098
PMC: 9548644.
DOI: 10.3389/fpsyt.2022.1000560.